Pulmonary Fibrosis
Welcome,         Profile    Billing    Logout  
 34 Companies   30 Products   30 Products   48 Mechanisms of Action   1 Trial   291 News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pulmonary Fibrosis
NCT02230982: Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis

No Longer Available
N/A
RoW
nintedanib
Boehringer Ingelheim
Idiopathic Pulmonary Fibrosis
 
 

Download Options